Immunome, Inc.IMNMNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-3005.63%
↓ 393% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
-609.93%
Historical baseline
PeriodValueYoY Change
TTM-3005.63%-79.5%
2024-1674.08%-738.1%
2023-199.74%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-